275,000 Shares in Mirion Technologies, Inc. $MIR Bought by Maven Securities LTD

Maven Securities LTD purchased a new stake in Mirion Technologies, Inc. (NYSE:MIR) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 275,000 shares of the company’s stock, valued at approximately $6,396,000. Maven Securities LTD owned approximately 0.11% of Mirion Technologies at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in MIR. Advisory Services Network LLC purchased a new stake in shares of Mirion Technologies in the third quarter worth about $25,000. Wolff Wiese Magana LLC purchased a new stake in shares of Mirion Technologies during the 3rd quarter valued at about $26,000. Salomon & Ludwin LLC acquired a new position in Mirion Technologies during the 3rd quarter worth approximately $30,000. Fortress Investment Group LLC purchased a new position in Mirion Technologies in the 2nd quarter worth approximately $32,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in Mirion Technologies by 470.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,642 shares of the company’s stock worth $35,000 after acquiring an additional 1,354 shares during the period. 78.51% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Mirion Technologies from $33.00 to $30.00 and set an “overweight” rating on the stock in a research note on Monday, March 9th. Evercore assumed coverage on shares of Mirion Technologies in a research note on Tuesday, November 25th. They issued an “outperform” rating and a $29.00 target price for the company. Morgan Stanley lowered their price target on shares of Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating for the company in a report on Wednesday, March 11th. Citigroup dropped their price target on shares of Mirion Technologies from $32.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, February 12th. Finally, The Goldman Sachs Group decreased their price objective on shares of Mirion Technologies from $33.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $27.63.

Mirion Technologies Stock Performance

Mirion Technologies stock opened at $19.26 on Wednesday. Mirion Technologies, Inc. has a 52 week low of $12.00 and a 52 week high of $30.28. The company has a current ratio of 2.83, a quick ratio of 2.34 and a debt-to-equity ratio of 0.62. The stock has a market cap of $4.82 billion, a P/E ratio of 175.07 and a beta of 0.99. The stock has a 50 day moving average of $23.31 and a 200-day moving average of $23.99.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.01). The company had revenue of $277.40 million during the quarter, compared to the consensus estimate of $281.17 million. Mirion Technologies had a return on equity of 6.97% and a net margin of 3.11%.The firm’s quarterly revenue was up 9.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.17 EPS. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. On average, analysts expect that Mirion Technologies, Inc. will post 0.39 EPS for the current fiscal year.

About Mirion Technologies

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.